382 related articles for article (PubMed ID: 12217209)
1. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
Wang Q; Hyde DM; Gotwals PJ; Giri SN
Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
[TBL] [Abstract][Full Text] [Related]
2. Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.
Wang Q; Wang Y; Hyde DM; Gotwals PJ; Koteliansky VE; Ryan ST; Giri SN
Thorax; 1999 Sep; 54(9):805-12. PubMed ID: 10456973
[TBL] [Abstract][Full Text] [Related]
3. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model.
Iyer SN; Margolin SB; Hyde DM; Giri SN
Exp Lung Res; 1998; 24(1):119-32. PubMed ID: 9457473
[TBL] [Abstract][Full Text] [Related]
4. Abatement of bleomycin-induced increases in vascular permeability, inflammatory cell infiltration, and fibrotic lesions in hamster lungs by combined treatment with taurine and niacin.
Wang Q; Hyde DM; Giri SN
Lab Invest; 1992 Aug; 67(2):234-42. PubMed ID: 1380105
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis.
Giri SN; Hyde DM; Braun RK; Gaarde W; Harper JR; Pierschbacher MD
Biochem Pharmacol; 1997 Dec; 54(11):1205-16. PubMed ID: 9416971
[TBL] [Abstract][Full Text] [Related]
6. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
Iyer SN; Gurujeyalakshmi G; Giri SN
J Pharmacol Exp Ther; 1999 Oct; 291(1):367-73. PubMed ID: 10490926
[TBL] [Abstract][Full Text] [Related]
7. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
Iyer SN; Wild JS; Schiedt MJ; Hyde DM; Margolin SB; Giri SN
J Lab Clin Med; 1995 Jun; 125(6):779-85. PubMed ID: 7539478
[TBL] [Abstract][Full Text] [Related]
8. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
Iyer SN; Gurujeyalakshmi G; Giri SN
J Pharmacol Exp Ther; 1999 Apr; 289(1):211-8. PubMed ID: 10087006
[TBL] [Abstract][Full Text] [Related]
9. Procollagen gene expression is down-regulated by taurine and niacin at the transcriptional level in the bleomycin hamster model of lung fibrosis.
Gurujeyalakshmi G; Iyer SN; Hollinger MA; Giri SN
J Pharmacol Exp Ther; 1996 May; 277(2):1152-7. PubMed ID: 8627527
[TBL] [Abstract][Full Text] [Related]
10. Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis.
Gurujeyalakshmi G; Hollinger MA; Giri SN
Am J Respir Cell Mol Biol; 1998 Mar; 18(3):334-42. PubMed ID: 9490651
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.
Chen J; Ziboh V; Giri SN
J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters.
Giri SN; Sharma AK; Hyde DM; Wild JS
Exp Lung Res; 1995; 21(2):287-307. PubMed ID: 7539741
[TBL] [Abstract][Full Text] [Related]
13. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
Gurujeyalakshmi G; Wang Y; Giri SN
J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice.
Giri SN; Biring I; Nguyen T; Wang Q; Hyde DM
Nitric Oxide; 2002 Sep; 7(2):109-18. PubMed ID: 12223180
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
16. Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats.
Gong LK; Li XH; Wang H; Zhang L; Chen FP; Cai Y; Qi XM; Liu LL; Liu YZ; Wu XF; Huang CG; Ren J
J Ethnopharmacol; 2005 Jan; 96(3):537-44. PubMed ID: 15619575
[TBL] [Abstract][Full Text] [Related]
17. Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence.
Giri SN; Hyde DM
Am J Pathol; 1988 Dec; 133(3):525-36. PubMed ID: 2462354
[TBL] [Abstract][Full Text] [Related]
18. Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters.
Giri SN; Hyde DM; Schiedt MJ
J Lab Clin Med; 1988 Jun; 111(6):715-24. PubMed ID: 2453601
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factor-beta type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis.
Zhao Y; Shah DU
Exp Mol Pathol; 2000 Oct; 69(2):67-78. PubMed ID: 11001857
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis.
Sriram N; Kalayarasan S; Sudhandiran G
Chem Biol Interact; 2009 Jul; 180(2):271-80. PubMed ID: 19497426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
